DLGAP1-AS1

Across TCGA pan-cancer cohorts, DLGAP1-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of DLGAP1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where DLGAP1-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types DLGAP1-AS1 is over-expressed in tumor, although a few such as KICH and KIRC show the opposite, repressed pattern.

KICH, KIRC, and LIHC are the cancer types where DLGAP1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLGAP1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	III,IV	−2.198	<.001	11	view →
KIRC	All	II,III,IV	−0.578	<.001	9	view →
LIHC	Male	II,III,IV	+1.868	<.001	8	view →
HNSC	Male	III,IV	+0.870	<.001	8	view →
COAD	Female	All	+0.756	<.001	6	view →
BRCA	All	All	+0.242	.001	6	view →
CHOL	Male	All	+2.315	<.001	5	view →
LUAD	All	IV	+0.850	.012	5	view →
STAD	Male	II,III,IV	+0.883	.004	4	view →
THCA	All	II,III,IV	+0.419	.006	3	view →
READ	All	All	+0.732	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

DLGAP1-AS1–KICH

Open the KICH breakdown →